Psychedelics Archives - Page 4 of 10

Rethinking the need for double-blind placebo trials in psychedelic clinical investigations

Commentary by Madison Carlino

Psychedelic treatment for neurodegenerative disorders

Policy Brief by Madison Carlino

Psychedelic therapy offers possible new hope for Alzheimer’s disease sufferers

Commentary by Madison Carlino

Psychedelics Policy Newsletter: Trump administration recommendations, Massachusetts loss, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — December 2024

Commentary by Gregory Ferenstein

Psychedelic drug policy recommendations for the incoming Trump administration

Backgrounder by Geoffrey Lawrence, Leonard Gilroy and Gregory Ferenstein

Psilocybin access would improve mental health care in Massachusetts

Commentary by Gregory Ferenstein

Psychedelics Policy Newsletter: MDMA rejection, advocating for lower state fees in Colorado, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — September 2024

Commentary by Gregory Ferenstein

More Psychedelics

Prev
1
2
3
4
5
6
7
...
10
Next